S&P 500   3,320.79 (-0.27%)
DOW   29,161.94 (-0.63%)
QQQ   223.03 (-0.16%)
AAPL   316.55 (-0.68%)
FB   221.08 (-0.48%)
MSFT   166.76 (-0.20%)
GOOGL   1,479.04 (-0.03%)
CGC   24.08 (-3.25%)
NVDA   247.48 (-0.72%)
BABA   221.57 (-2.58%)
MU   58.60 (+1.63%)
GE   11.67 (-1.27%)
TSLA   542.24 (+6.22%)
AMD   50.86 (-0.16%)
T   38.56 (+0.47%)
ACB   1.98 (-7.06%)
F   9.18 (+0.22%)
NFLX   334.24 (-1.60%)
PRI   127.32 (-0.86%)
BAC   34.37 (-0.98%)
GILD   62.84 (-0.22%)
DIS   143.35 (-0.68%)
S&P 500   3,320.79 (-0.27%)
DOW   29,161.94 (-0.63%)
QQQ   223.03 (-0.16%)
AAPL   316.55 (-0.68%)
FB   221.08 (-0.48%)
MSFT   166.76 (-0.20%)
GOOGL   1,479.04 (-0.03%)
CGC   24.08 (-3.25%)
NVDA   247.48 (-0.72%)
BABA   221.57 (-2.58%)
MU   58.60 (+1.63%)
GE   11.67 (-1.27%)
TSLA   542.24 (+6.22%)
AMD   50.86 (-0.16%)
T   38.56 (+0.47%)
ACB   1.98 (-7.06%)
F   9.18 (+0.22%)
NFLX   334.24 (-1.60%)
PRI   127.32 (-0.86%)
BAC   34.37 (-0.98%)
GILD   62.84 (-0.22%)
DIS   143.35 (-0.68%)
S&P 500   3,320.79 (-0.27%)
DOW   29,161.94 (-0.63%)
QQQ   223.03 (-0.16%)
AAPL   316.55 (-0.68%)
FB   221.08 (-0.48%)
MSFT   166.76 (-0.20%)
GOOGL   1,479.04 (-0.03%)
CGC   24.08 (-3.25%)
NVDA   247.48 (-0.72%)
BABA   221.57 (-2.58%)
MU   58.60 (+1.63%)
GE   11.67 (-1.27%)
TSLA   542.24 (+6.22%)
AMD   50.86 (-0.16%)
T   38.56 (+0.47%)
ACB   1.98 (-7.06%)
F   9.18 (+0.22%)
NFLX   334.24 (-1.60%)
PRI   127.32 (-0.86%)
BAC   34.37 (-0.98%)
GILD   62.84 (-0.22%)
DIS   143.35 (-0.68%)
S&P 500   3,320.79 (-0.27%)
DOW   29,161.94 (-0.63%)
QQQ   223.03 (-0.16%)
AAPL   316.55 (-0.68%)
FB   221.08 (-0.48%)
MSFT   166.76 (-0.20%)
GOOGL   1,479.04 (-0.03%)
CGC   24.08 (-3.25%)
NVDA   247.48 (-0.72%)
BABA   221.57 (-2.58%)
MU   58.60 (+1.63%)
GE   11.67 (-1.27%)
TSLA   542.24 (+6.22%)
AMD   50.86 (-0.16%)
T   38.56 (+0.47%)
ACB   1.98 (-7.06%)
F   9.18 (+0.22%)
NFLX   334.24 (-1.60%)
PRI   127.32 (-0.86%)
BAC   34.37 (-0.98%)
GILD   62.84 (-0.22%)
DIS   143.35 (-0.68%)
Log in
(Ad)
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

TSE:PJC.A - Jean Coutu Group Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
C$24.50
0.00 (0.00 %)
(As of 05/14/2018)
Add
Today's Range
C$24.48
Now: C$24.50▼
C$24.51
50-Day Range N/A
52-Week Range
C$19.24
Now: C$24.50▼
C$24.90
Volume664,286 shs
Average Volume126,739 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees. Read More…

Industry, Sector and Symbol

Stock Exchange TSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolTSE:PJC.A
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.jeancoutu.com/
Phone+1-450-6469760

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PJC.A News and Ratings via Email

Sign-up to receive the latest news and ratings for PJC.A and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Jean Coutu Group (TSE:PJC.A) Frequently Asked Questions

What is Jean Coutu Group's stock symbol?

Jean Coutu Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PJC.A."

Has Jean Coutu Group been receiving favorable news coverage?

Media coverage about PJC.A stock has been trending positive recently, InfoTrie reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Jean Coutu Group earned a news sentiment score of 2.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Jean Coutu Group.

What other stocks do shareholders of Jean Coutu Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jean Coutu Group investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), Pason Systems (PSI), Lightspeed POS (LSPD), AbbVie (ABBV), ONEX (ONEX), Vermilion Energy (VET) and Wheaton Precious Metals (WPM).

Who are Jean Coutu Group's key executives?

Jean Coutu Group's management team includes the folowing people:
  • Jean Coutu, Chairman of the Board
  • Francois Jean Coutu, President, Chief Executive Officer, Non-Independent Director
  • Nicolle Forget QC, Independent Vice Chairman of the Board
  • Marcel A. Raymond, President of Pro-Doc Ltee
  • Andre Belzile, Executive Vice President - Finance and Corporate Affairs
  • Alain Lafortune, Executive Vice President - Purchasing and Marketing
  • Jean-Michel Coutu, Executive Vice President - Retail Operations and Distribution
  • Richard Mayrand, Executive Vice President - Pharmacy and Governmental Affairs
  • Normand Messier, Executive Vice President - Franchise Development and Operations
  • Alain Boudreault, Chief Information Officer, Vice President

What is Jean Coutu Group's stock price today?

One share of PJC.A stock can currently be purchased for approximately C$24.50.

What is Jean Coutu Group's official website?

The official website for Jean Coutu Group is http://www.jeancoutu.com/.

How can I contact Jean Coutu Group?

Jean Coutu Group's mailing address is 530 Beriault St, LONGUEUIL, QC J4G 1S8, Canada. The company can be reached via phone at +1-450-6469760.


MarketBeat Community Rating for Jean Coutu Group (TSE PJC.A)

Community Ranking:  0.8 out of 5 ()
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  386 (Vote Underperform)
Total Votes:  459
MarketBeat's community ratings are surveys of what our community members think about Jean Coutu Group and other stocks. Vote "Outperform" if you believe PJC.A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PJC.A will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Featured Article: Support Level
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel